Diabeloop

Diabeloop's mission: to relieve people living with Type 1 diabetes from 100+ daily therapeutic decisions and reduce their heavy mental burden. Initially conceived from a medical research project, Diabeloop was created in 2015 by Dr. Guillaume Charpentier and Erik Huneker. This complementary management team works with experienced partners such as French technology research key-player CEA-Leti. In 2018, DBLG1 System, Diabeloop's first medical device for automated diabetes management, obtained CE marking, followed by DBL-hu, its solution for highly unstable Type 1 diabetes management in 2020. Today, Diabeloop gathers the personality, the passion and the skills of over 100 talented individuals who work hard to improve the quality of life for every person living with diabetes.

77.0logo
logo
logo
logo
logo
logo
77.0
logo
NaN
logo
NaN
logo
NaN
logo
NaN
Links
logo
logologologo
Valuation
logo
$
Valuation
Funding
logo
$
$ 74.91 M
$ 132.10 M
Funding
$ 74.91 M
$ 132.10 M
Statistics
logo
NA
Action

Diabeloop's mission: to relieve people living with Type 1 diabetes from 100+ daily therapeutic decisions and reduce their heavy mental burden. Initially conceived from a medical research project, Diabeloop was created in 2015 by Dr. Guillaume Charpentier and Erik Huneker. This complementary management team works with experienced partners such as French technology research key-player CEA-Leti. In 2018, DBLG1 System, Diabeloop's first medical device for automated diabetes management, obtained CE marking, followed by DBL-hu, its solution for highly unstable Type 1 diabetes management in 2020. Today, Diabeloop gathers the personality, the passion and the skills of over 100 talented individuals who work hard to improve the quality of life for every person living with diabetes.

Overview
Last verified: 10/15/2022
Merck KGaAMerck KGaAMerck KGaAMerck KGaAMerck KGaA 
View All
logologologo
0and0